Newsbenzinga
BioStem Technologies Announces It Received Nasdaq Approval For The Company’s Common Stock For Listing On The Nasdaq Capital Market; Co. To Begin Trading On Nasdaq On August 7, 2026 Under The Ticker Symbol "BSEM"
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…